Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells  by Takubo, Keiyo et al.
Cell Stem Cell
ArticleRegulation of the HIF-1a Level Is Essential
for Hematopoietic Stem Cells
Keiyo Takubo,1,* Nobuhito Goda,3,6 Wakako Yamada,1 Hirono Iriuchishima,1 Eiji Ikeda,4 Yoshiaki Kubota,1
Haruko Shima,1 Randall S. Johnson,5 Atsushi Hirao,6,7 Makoto Suematsu,2 and Toshio Suda1,*
1Department of Cell Differentiation, The Sakaguchi Laboratory of Developmental Biology, Keio University School of Medicine,
35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan
2Department of Biochemistry, Keio University School of Medicine and JST-ERATO, Suematsu Gas Biology Project, 35 Shinano-machi,
Shinjuku-ku, Tokyo 160-8582, Japan
3Department of Life Science and Medical Bio-Science, School of Advanced Science and Engineering, Waseda University,
2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo, 162-8480, Japan
4Department of Pathology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan
5Molecular Biology Section, Division of Biological Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
6Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Chiyoda-ku, Tokyo 102-0075, Japan
7Division of Molecular Genetics, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan
*Correspondence: keiyot@gmail.com (K.T.), sudato@sc.itc.keio.ac.jp (T.S.)
DOI 10.1016/j.stem.2010.06.020SUMMARY
Hematopoietic stem cells (HSCs) are sustained in
a specific microenvironment known as the stem cell
niche. Mammalian HSCs are kept quiescent in the
endosteal niche, a hypoxic zone of the bone marrow
(BM). In this study, we show that normal HSCs
maintain intracellular hypoxia and stabilize hypoxia-
inducible factor-1a (HIF-1a) protein. In HIF-1a-defi-
cient mice, the HSCs lost their cell cycle quiescence
and HSC numbers decreased during various stress
settings including bone marrow transplantation,
myelosuppression, or aging, in a p16Ink4a/p19Arf-
dependent manner. Overstabilization of HIF-1a by
biallelic loss of an E3 ubiquitin ligase for HIF-1a
(VHL) induced cell cycle quiescence in HSCs and
their progenitors but resulted in an impairment in
transplantation capacity. In contrast, monoallelic
loss of VHL induced cell cycle quiescence and
improved BM engraftment during bone marrow
transplantation. These data indicate that HSCsmain-
tain cell cycle quiescence through the precise regula-
tion of HIF-1a levels.
INTRODUCTION
Stem cells localize to specific sites, or ‘‘niches,’’ in the tissues,
where they are preferentially maintained by various environ-
mental factors (Scadden, 2006; Morrison and Spradling, 2008;
Li and Xie, 2005). Mammalian bone marrow (BM) has been sug-
gested to be relatively hypoxic compared to other tissues, and
primitive hematopoietic cells including hematopoietic stem cells
(HSCs) are thought to be localized in the most hypoxic microen-
vironment of the BM (Cipolleschi et al., 1993; Levesque et al.,
2007; Parmar et al., 2007; Kubota et al., 2008). The hypoxic
ex vivo culture of BM cells or primitive hematopoietic progenitorsCellresults in maintenance of the primitive phenotype (Danet et al.,
2003) and cell cycle quiescence (Hermitte et al., 2006). Ex vivo
culture of human HSCs under hypoxia also stabilizes the
hypoxia-inducible factor-1a (HIF-1a) protein, a master transcrip-
tional regulator of the cellular and systemic hypoxia response,
and several downstream effectors of HIF-1a (Danet et al.,
2003). However, the regulatory mechanism and functional
effects of BM hypoxia on HSCs in vivo has not been fully eluci-
dated.
In the stem cell niche, HSCs are quiescent and show slow cell
cycling. Various extracellular ligands, including CXCL12, angio-
poietin-1, and/or thrombopoietin (TPO), contribute the quies-
cence of HSCs (Sugiyama et al., 2006; Arai et al., 2004;
Yoshihara et al., 2007). Quiescent HSCs are maintained at
a lower oxidative stress state to avoid their differentiation and
exhaustion (Jang and Sharkis, 2007). HIF-1a is a bHLH-PAS-
type transcriptional regulator. Under normoxic conditions, prolyl
residues in the HIF-1a oxygen-dependent degradation domain
(ODD) are hydroxylated by HIF prolyl hydroxylases (Phds)
(Semenza, 2007; Simon and Keith, 2008). The hydroxylated
ODD domain of HIF-1a protein is recognized by an E3 ubiquitin
ligase, von Hippel-Lindau protein (VHL). In the autosomal-domi-
nant hereditary disorder von Hippel Lindau disease, the VHL is
mutated, resulting in overstabilized HIF-1a protein by the
impaired ubiquitin proteasome pathway. Under hypoxic condi-
tions, Phds are inactivated and HIF-1a protein escapes protein
degradation. Several niche factors, such as TPO and stem cell
factor (SCF), also stabilize HIF-1a protein in hematopoietic cells
even under normoxia conditions (Kirito et al., 2005; Pedersen
et al., 2008).
Stabilized HIF-1a protein forms a heterodimeric transcriptional
complex with the oxygen-independent subunit HIF-1b,
translocates to the nucleus, and directly binds hypoxia-respon-
sive elements found in the promoter regions of numerous
downstream regulators, thereby activating these regulators
(Semenza, 2007; Simon and Keith, 2008). HIF-1b is reportedly
required for hematopoietic cell generation during ontogeny
(Adelman et al., 1999). However, a detailed analysis of the contri-
bution of HIF-1a to the maintenance of adult HSCs has not yetStem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier Inc. 391
Figure 1. HSCs Are Hypoxic and Stabilize HIF-1a Protein
(A) FACS analysis of intracellular pimonidazole (Pimo) and the Tie2+ fraction in LineagemarkerSca-1+ c-Kit+ (LSK) cells. Intracellular Pimowas detected using an
anti-Pimo-FITC antibody. Whole BMMNCs from 12-week-old wild-type mice were subdivided into three fractions (30%, 40%, and 30%, respectively) based on
their Pimo fluorescence levels: highly (navy; Pimo+++), moderately (blue; Pimo++), or weakly (pale blue; Pimo+) Pimo positive (left panel). The Tie2 expression in
LSK-gated cells is shown in the right panel. Data represent the means ± SDs (n = 5).
(B) Oxygenation status of 12-week-old wild-type BM fractions, including BMMNCs, Lineagemarker (Lin) , LSK, and LT-HSC (CD150+ CD48- CD41- LSK). Pimo-
positive BM fractions were determined as in (A). The total cell number was set to 100% and the relative percentage of individual fractions was calculated by flow
cytometric analysis (n = 5).
(C) Expression of HIF-a family transcripts (HIF-1a, HIF-2a, and HIF-3a) in 10-week-old CD34- LSK, CD34+ LSK, Lin, or Lin+ cells. Each value was normalized to
b-actin expression and is expressed as the fold induction compared to levels detected in CD34- LSK samples (mean ± SD, *p < 0.05, n = 4).
(D–F) Immunohistochemical analysis of the BM for c-Kit (gray), Pimo (green), and HIF-1a (red) (D); c-Kit (gray), Pimo (green), and Foxo3a (red) (E); or c-Kit (gray),
HIF-1a (green), and Foxo3a (red) (F). Arrows indicate cells that are positive for both green and red signals in the nucleus of c-Kit+ cells.
(G–J) Immunocytochemical detection of HIF-1a (green), Foxo3a (red), and c-Kit (gray) in HSCs (G andH) or progenitors (I and J) exposed to 12 hr of hypoxia (G and
I) or normoxia (H and J) without cytokines. The preferential stabilization of HIF-1a was observed in HSCs under hypoxia.
(K) Expression of Phd1, Phd2, Phd3, and VHL transcripts in 10-week-old CD34- LSK, CD34+ LSK, Lin, or Lin+ cells. Each valuewas normalized to b-actin expres-
sion and is expressed as the fold induction compared to levels detected in CD34 LSK samples (mean ± SD, *p < 0.05, n = 4).
See also Figure S1.
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HIF-1a/VHL Regulatory System in HSC Homeostasisbeen reported. Therefore, in the present study, we analyzed
HSCs in HIF-1a- and VHL-deficient mice and found that the
cellular pool and cell cycle status of HSCs were regulated by
the HIF-1a level. Our analysis revealed that the regulation of
the HIF-1a dose is critical for HSC maintenance in the hypoxic
niche microenvironment of the BM.
RESULTS
HSCs Are Hypoxic in the Bone Marrow and Express
HIF-1a Protein In Vivo
To analyze the intracellular oxygenation status of HSCs, we
examined the uptake of the hypoxic cell marker pimonidazole
(Pimo) by BM cells in vivo (Figure 1A). Intracellular incorporation
of Pimo was analyzed by multicolor flow cytometry with392 Cell Stem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier Ina fluorescein (FITC)-conjugated anti-Pimo antibody 90 min after
intravenous Pimo administration into mice. The BM MNCs were
subdivided into highly (Pimo+++; top 30% of BM MNCs),
moderately (Pimo++; middle 40% of BM MNCs), and weakly
(Pimo+; bottom 30% of BM MNCs) Pimo-positive fractions.
The distribution of Tie2+ cells in Lineage marker Sca-1+ c-Kit+
cells (Tie2+ LSK cells), which represent quiescent HSCs (Arai
et al., 2004), was clearly enriched in the Pimo+++ fraction of BM
MNCs (Figure 1A). The Pimo+++ fraction contained 68.2% of
the LT-HSC (long-term reconstituting HSC) fraction that is
made up of CD150+ CD48 CD41 LSK cells, (Kiel et al., 2005)
and 62.4% of the LSK fraction (Figure 1B). In sharp contrast,
the Pimo+ fraction only contained 1.8% of the CD150+ CD48
CD41 LSK fraction and 3.5% of the LSK fraction (Figure 1B).
Because 30% of the MNCs and 44.5% of the Lineagec.
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HIF-1a/VHL Regulatory System in HSC Homeostasismarker-negative (Lin) cells were Pimo+ (Figure 1B), we
conclude that primitive hematopoietic cells, including CD150+
CD48 CD41 LSK, Tie2+ LSK, and LSK cells, are hypoxic in
the BM in vivo.
Next, the mRNA expression levels of three HIF-a subunits,
HIF-1a, -2a, and -3a, in CD34 LSK (the fraction of LT-HSC
[Osawa et al., 1996], CD34+ LSK (short-term reconstituting
HSC; ST-HSC and multi-potent progenitor; MPP), Lin, and
Lin+ cells in 10-week-old BM were confirmed by quantitative
PCR. The HIF-1a expression was higher in the more primitive
fractions than in the differentiated fraction, and expression was
highest in CD34 LSK cells (Figure 1C). Consistent with this,
among the three homologs of the hypoxia-regulated HIF-a
subunits, the online SAGE database SCDb (Hackney andMoore,
2005) shows the preferential expression of the HIF-1a transcript
(SCDb ID: BMSB10895) in adult mouse HSCs (BM Rhodaminelo
Hoechstlo) rather than in the differentiated cell fraction (Lin+).
In our analysis, the expression level of HIF-2amRNA in CD34
LSK cells was higher than in CD34+ LSK cells. However, the
highest expression among the four fractions was observed in
Lin cells. HIF-2a protein was mainly observed in the cytoplasm
of CD34 LSK or CD34+ LSK cells after hypoxic exposure ex vivo
(Figure S1A available online). The expression level of the most
uncharacterized HIF-a subunit, HIF-3a, was highest in the
CD34 LSK fraction. Although the effect of HIF-3a on the cellular
hypoxia response remains to be elucidated, HIF-3a itself is
a direct transcriptional target of HIF-1a (Tanaka et al., 2009).
Therefore, high HIF-3a expression levels in the CD34 LSK frac-
tion implicate the preferential activation of HIF-1a in LT-HSCs.
To analyze the HIF-1a protein expression in situ, we performed
immunohistochemical analysis of BM sections with anti-Pimo,
anti-HIF-1a, and anti-Foxo3a antibodies. Foxo3a is a forkhead-
type transcription factor that is essential for HSC quiescence
(Tothova et al., 2007; Miyamoto et al., 2007). Because Foxo3a
is only retained within LT-HSC nuclei and is excluded from
ST-HSC/MPP nuclei, nuclear Foxo3a is a marker for quiescent
HSCs (Miyamoto et al., 2007). More than 86.8% of the Pimo+
c-Kit+ cells possessed nuclear HIF-1a and Foxo3a (Figures 1D
and 1E). Of the c-Kit+ HIF-1a+ cells, 95.4% had nuclear-localized
Foxo3a, suggesting that the c-Kit+ HIF-1a+ Foxo3a+ (KHF) cells
were putative LT-HSCs in the BM (Figure 1F). In addition, 70.0%
of the KHF cells localized to the endosteal zone of the BM, as re-
ported previously (Kubota et al., 2008). Immunohistochemical
analysis of the BMwith SLAMmarkers (Kiel et al., 2005) revealed
that these SLAM HSCs also expressed HIF-1a in vivo (Fig-
ure S1B).
We next examined the pure effect of hypoxia onHIF-1a protein
stabilization. Isolated CD34 LSK or CD34+ LSK cells were
exposed to normoxia (20% O2) or hypoxia (1% O2) without
cytokines for 12 hr, after which the c-Kit, HIF-1a, and Foxo3a
protein levels were examined by immunocytochemistry (Figures
1G–1J). Stabilization of the nuclear HIF-1a protein was mainly
observed in CD34 LSK cell samples exposed to hypoxia
(Figure 1G). Levels of stabilized nuclear HIF-1a protein were rela-
tively low in CD34 LSK cell samples exposed to normoxia and in
CD34+ LSK cell samples exposed to any oxygen tension (Figures
1H–1J). Effects of hypoxia and HIF-1a-stabilizing cytokines SCF
and TPO on HIF-1a levels were examined by quantification of
HIF-1a fluorescence intensity in LT-HSCs (CD34 Flt3 LSK)Cellor CD34+ LSK cells (Figure S1C). Without cytokines or hypoxic
exposure, HIF-1a fluorescence intensity in LT-HSCs was higher
than in CD34+ LSK cells. Exposure to cytokines or hypoxia stabi-
lized HIF-1a protein in LT-HSCs and CD34+ LSK cells
(Figure S1C). However, HIF-1a was highly stabilized in LT-HSC
cells (Figure S1C). In contrast, cytokines induced HIF-1a stabili-
zation more efficiently in CD34+ LSK cells (Figure S1C).
The expression levels of Phd and VHL, the essential HIF-a
degradation machinery, potentially help determine the set point
for HIF-1a stabilization. To analyze the specific destabilization
mechanism in CD34+ LSK cells, we performed quantitative
PCR analysis for Phds and VHL (Figure 1K). The expression level
of Phd2 was higher in CD34+ LSK cells than in CD34 LSK cells
(Figure 1K). Of the Phd family members, Phd2 is the one most
responsible for HIF-1a stabilization (Semenza, 2007). Thus, the
higher Phd2 expression in CD34+ LSK cells could be a regulatory
mechanism for the preferential degradation of HIF-1a in CD34+
LSK cells exposed to hypoxia. These data collectively suggest
the specific contribution of HIF-1a to HSC maintenance in vivo.
Defective Maintenance of HIF-1aD/D HSCs against
Transplantation through Ink4a/Arf
We next examined the functional effect of HIF-1a on the quies-
cent state of HSCs by analyzing an inducible HIF-1a deletion
model in vivo. To delete the HIF-1a gene fromHSCs, we induced
the Cre transgene in Mx1-Cre:HIF-1aflox/flox mice (Ryan et al.,
1998; Kuhn et al., 1995) by sequential polyI:polyC (pIpC) injec-
tions, which efficiently excised the HIF-1a gene from the hema-
tological organs and peripheral blood (PB) cells (Figures S1D,
S1E, S1H, and S1I). The deletion was maintained for at least
2 years in vivo (Figures S1H and S1I). In this mouse model
(HIF-1aD/D mice), the PB cell count and differentiation statuses
of PB, thymus, spleen, and BM cells were maintained, except
for a slight increase in leukocyte numbers and a reduction in
the mean corpuscular volume (MCV) (Figures 2A and Figures
S1F and S1G). Therefore, the overall differentiation capacity of
HIF-1aD/D HSCs was identical to that of HIF-1a+/+ HSCs at
steady state.
We next assessed the progenitor capacity of HIF-1aD/D BM
MNCs. The conventional hematopoietic progenitor assays
CFU-C and CFU-S12 revealed no significant difference between
HIF-1a+/+ and HIF-1aD/D BM MNCs (Figures S2A and S2B).
In addition, the short-term (4 week) PB reconstitution abilities
by sorted HIF-1aD/D CD34+ LSK cells transplanted into lethally
irradiated Ly5.1 congenic recipients with Ly5.1 competitor cells
were identical between the two genotypes (Figures S2C). There-
fore, the short-term reconstitution ability of CD34+ LSK cells
(ST-HSCs and MPP cells) was normal under the HIF-1aD/D
condition.
We evaluated the stem cell capacity of HIF-1aD/D HSCs by
competitive BM transplantation (BMT). We transplanted 2000
LSK cells sorted from HIF-1a+/+ or HIF-1aD/D mice into lethally
irradiated Ly5.1 congenic recipients with Ly5.1 competitor cells.
In 12-week-oldHIF-1aD/Dmice (1–2months after pIpC injection),
the frequency of the LSK cells and the more primitive subfrac-
tions of LSK cells (CD150+ CD48 CD41 LSK, Tie2+ LSK, or
CD34 Flt3 LSK cells) were similar to those in HIF-1a+/+ mice
(Figure S2D). In primary recipients, the HIF-1aD/D donor cells
achieved significantly greater PB chimerism for up to 3 monthsStem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier Inc. 393
Figure 2. Defective Maintenance of HIF-1aD/D HSCs against Transplantation through Ink4a/Arf
(A) Peripheral blood counts of HIF-1a+/+ or HIF-1aD/D mice (mean ± SD, n = 24).
(B) PB chimerism in primary BMT recipients of HIF-1a+/+ (open boxes) or HIF-1aD/D LSK (closed boxes) cells at the indicated times after BMT (mean ± SD,
*p < 0.001, n = 10).
(C and D) Donor-derived (Ly5.2+) BMMNC chimerism (C) or LSK chimerism (D) in primary BMT recipients ofHIF-1a+/+ (open bars) or HIF-1aD/D LSK (closed bars)
cells 4 months after primary BMT (mean ± SD, n = 5).
(E) Differentiation status (CD4/CD8+ T cells, B220+ B cells, or Mac-1/Gr-1+myeloid cells) of donor-derived (Ly5.2+) PB cells in primary BMT recipients ofHIF-1a+/+
(open bars) or HIF-1aD/D LSK (closed bars) cells (mean ± SD, n = 10).
(F) Quantitative PCR analysis of p16Ink4a and p19Arf in HIF-1a+/+ (open bars) or HIF-1aD/D (closed bars) donor-derived LSK cells at 4 months after primary BMT
(n = 4). Each value was normalized to b-actin expression and is expressed as the fold induction compared to levels detected in HIF-1a+/+ Ly5.2+ LSK samples
(mean ± SD, *p < 0.01).
(G) PB chimerism in secondary BMT recipients of HIF-1a+/+ (open boxes) or HIF-1aD/D (closed boxes) Ly5.2+ LSK cells at the indicated times after BMT
(mean ± SD, *p < 0.001, n = 10).
(H and I) BM chimerism in secondary BMT recipients ofHIF-1a+/+ (open bars) orHIF-1aD/D (closed bars) LSK cells at 4months after secondary BMT.Graphs show
the donor-derived chimerism (Ly5.2+) of BM MNCs (H) or LSK cells (I) (mean ± SD, n = 5).
(J) Study design of the suppression of Ink4a products by Bmi1 expression in HIF-1aD/D LSK cells.
(K) Quantitative PCR analysis of Ink4a products (p16Ink4a and p19Arf) in LSK cells transduced with GFP or Bmi1 retrovirus for 48 hr in a HIF-1a+/+ or HIF-1aD/D
background (mean ± SD, n = 4, *p < 0.01).
(L) Donor-derived PB chimerism (Ly5.2+) of HIF-1a+/+ or HIF-1aD/D donor cells transduced with retroviruses carrying GFP or Bmi1 coding sequences at the indi-
cated times after BMT (mean ± SEM, *p < 0.05 compared to other groups, n = 5).
(M) Donor-derived BM LSK or CD34 LSK chimerism (Ly5.2+) of HIF-1a+/+ or HIF-1aD/D donor cells transduced with retroviruses carrying GFP or Bmi1 coding
sequences 4 months after BMT (mean ± SEM, n = 5).
See also Figure S2.
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HIF-1a/VHL Regulatory System in HSC Homeostasisafter BMT, and PB chimerism reached a plateau between 3 and
4 months after BMT (Figure 2B). Four months after BMT, recipi-
ents of the HIF-1aD/D donor cells exhibited less chimerism than
recipients of HIF-1a+/+ donor cells in the LSK-gated fraction of394 Cell Stem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier Inthe BM (Figures 2C and 2D), indicating that the HSC levels
were decreased. Spleens were also examined in the primary
recipients at four months after BMT. However, no evidence for
extramedullary hematopoietis was observed in HIF-1aD/D HSCc.
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HIF-1a/VHL Regulatory System in HSC Homeostasisrecipients (Figure S2E). At this time,HIF-1aD/D donor-derived PB
differentiation showed increased T andmyeloid cell and reduced
B cell counts (Figure 2E). Significant elevation of Ink4a transcrip-
tion, a hallmark of senescent stem cells (Naka et al., 2008), was
also detected in HIF-1aD/D LSK cells from primary BMT recipi-
ents (Figure 2F). We then isolated and transplanted 3000 primary
donor-derived LSK cells into secondary recipients. A devas-
tating loss in the long-term reconstitution ability of the HIF-1aD/D
HSCs was seen in the PB and BM of the secondary recipient
(Figures 2G–2I). Although surface marker analysis suggests
that the frequency of various HSC fractions is within normal limits
in young HIF-1aD/D mice (Figure S2D), the possibility exists that
HSC contents within the LSK fraction before BMT are already
compromised in HIF-1aD/D mice. To exclude this possibility,
we prepared 1:1 BM chimera by transplanting pIpC-untreated
Mx1-cre:HIF-1a+/+ or Mx1-cre:HIF-1aflox/flox BM MNCs with
identical numbers of CD45.1+ CD45.2+ competitor BM MNCs
(Figure S2F). pIpC was intraperitoneally injected 4 months after
BMT (‘‘0 month’’ in Figure S2G). Before the pIpC injections, the
PB repopulation unit (CD45.2+ donor-derived chimerism
[%]/CD45.1+ CD45.2+ competitor-derived chimerism [%]) was
identical for the two genotypes (Figure S2G). Four months after
the pIpC injection, the HIF-1aD/D PB repopulation unit over-
whelmed HIF-1a+/+ PB population in HIF-1a+/+ recipients (Fig-
ure S2G). However, at 11 months after the pIpC injection, the
level of the HIF-1aD/D PB repopulation had decreased below
the level of the HIF-1a+/+ PB repopulation unit. These data are
consistent with the experimental phenotype of LSK BMT
(Figures 2B and 2G) in primary recipients (4 months after pIpC
in 1:1 BM chimera) and secondary recipients (11 months after
pIpC in 1:1 BM chimera) and supports the progressive loss of
HIF-1aD/D HSCs during BMT.
To directly analyze the impact of upregulated Ink4a products
on HIF-1aD/D HSCs, we suppressed Ink4a products in HIF-
1aD/D LSK cells by using the retroviral Bmi1 expression vector
(Iwama et al., 2004) (Figure 2J). Isolated HIF-1aD/D LSK cells
were transduced by control MSCV-IRES-EGFP retrovirus (GFP
virus) or MSCV-Bmi1-IRES-EGFP retrovirus (Bmi1 virus) in an
ex vivo culture with cytokines under normoxia. After transduc-
tion, the HIF-1aD/D LSK cells transduced with GFP virus showed
significantly higher transcript levels of p16Ink4a and p19Arf than
the HIF-1a+/+ LSK cells transduced with GFP virus (Figure 2K).
This observation confirmed the vulnerability of HIF-1aD/D LSK
cells under stressed conditions (ex vivo culture) and following
BMT (Figure 2F).
Transduction of the Bmi1 virus into HIF-1aD/D LSK cells
suppressed the upregulation of p16Ink4a and p19Arf transcripts
compared to HIF-1aD/D LSK cells transduced with GFP virus
(Figure 2K). The sorting and transplantation of transduced cells
revealed defects in PB repopulation and BM reconstitution after
BMT in HIF-1aD/D LSK cells transduced with GFP virus (Figures
2L and 2M), which were significantly restored by the forced
expression of Bmi1 in HIF-1aD/D LSK cells (Figures 2L and 2M).
Collectively, these results indicate that the stem cell capacity,
but not the progenitor capacity or productivity of differentiated
HIF-1aD/D hematopoietic cells is impaired. Furthermore, other
Bmi1 targets in HSCs, Pax5, and Ebf1 (Oguro et al., 2010)
were not upregulated in HIF-1aD/D CD34 Flt3 LSK cells and
were not suppressed by overexpression of Bmi1 (FiguresCellS2H–S2J and data not shown); HIF-1a appears to play a protec-
tive role, mediated by Ink4a gene products, against senescence-
induced HSC exhaustion. Because transplantation of wild-type
CD45.1+ BM MNCs into HIF-1a+/+ or HIF-1aD/D mouse BM
environments caused a decrease in short-term reconstitution
(2 months from BMT) and a loss of PB differentiation status,
but not long-term reconstitution (4 months from BMT) (Figures
S2K and S2L), defective maintenance of HIF-1aD/D HSCs under
stress settings is mainly an cell-autonomous event.
Decreased Cellular Pool and Hypoxic Status of Aged
HIF-1aD/D HSCs
We next examined the physiological stress resistance of
HIF-1aD/D HSCs during aging. Aging significantly reduced the
frequency (Figure 3A and Figure S2D) and number (Figure 3B)
of putative HSCs (CD150+ CD48 CD41 LSK, Tie2+ LSK, or
CD34 Flt3 LSK cells) in 56- to 74-week-old HIF-1aD/D mice
compared to HIF-1a+/+ mice. In 24-week-old HIF-1aD/D mice
(i.e., when HSC loss has already started), more than 65%
of the CD150+ CD48- CD41 LSK or Tie2+ LSK cells were
Pimo+++ (Figures 3C and 3D) in accordance with the results in
Figure 1A. The Pimo+ fraction only contained less than 2% of
the CD150+ CD48 CD41 LSK or Tie2+ LSK fraction (Figures
3C and 3D). Tie2+ LSK or CD150+ CD48 CD41 LSK cell loss
was severe in the Pimo+++ fraction of HIF-1aD/D HSCs, and the
Pimo+ fraction was increased in Tie2+ LSK cells and CD150+
CD48 CD41 LSK cells (Figures 3C and 3D). Because the
mean Pimo fluorescence and distribution in total BM MNCs
was unchanged at this time (data not shown), the oxygenation
status (Pimo+++/Pimo++/Pimo+) in the HIF-1aD/D HSC pool might
not depend on the overall BM oxygenation status, but on the
HIF-1a-mediated intracellular oxygenation homeostasis of
HSCs. These results suggest that HIF-1a, by modulating the
oxygenation status of cells, critically regulates resistance to
various stresses, including aging, in hypoxic mammalian
HSCs. Moreover, in the aged HIF-1aD/D mice, we observed an
increased number of LSK cells in the extramedullary site, spleen
(Figure 3E). The red and white pulp structures of the spleen were
disorganized in the aged HIF-1aD/D mice because of extracel-
lular hematopoiesis (Figure 3F). Transplantation of 1 3 106
splenic MNCs rescued the lethally irradiated recipients (Fig-
ure 3G), which suggests that splenic LSK cells support the
hematopoiesis of recipient mice.
Cell Cycle Regulation of HSCs and Hematopoietic
Progenitors through HIF-1a
Sustaining cell cycle quiescence is an effective defense against
stress in various species, organs, and individual cells, including
mammalian HSCs (Arai et al., 2004). Therefore, to investigate
the mechanism of HSC loss in HIF-1aD/D mice, we focused on
the cell cycle of HIF-1aD/D HSCs. We sequentially injected the
myelosuppressive agent 5-FU into mice. Sequential injections
of a sublethal dose of 5-FU depletes cycling HSCs and causes
quiescent HSCs to proliferate (Miyamoto et al., 2007). HIF-1aD/D
mice showed significantly higher mortality rates than controls in
response to myelosuppression by 5-FU (Figure 4A). This was
primarily a hematopoietic cell-dependent event, given that recip-
ient mice with BM from HIF-1aD/D mice also showed higher
mortalities by 5-FU than controls (Figure S3A). The cell cycleStem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier Inc. 395
Figure 3. Loss and Altered Oxygenation Status of BM HSCs and Increased Extramedullar Hematopoiesis in Aged HIF-1aD/D Mice
(A) Flow cytometric analysis of various putative HSC fractions. FACS plots of HIF-1a+/+ or HIF-1aD/D BM in 56- to 74-week-old mice. LT HSC (CD150+ CD48
CD41 LSK cells; left column), LSK Tie2+ (center column), and LSK Flt3 CD34 (right column) fractions are indicated. Numbers indicate the percentage of total
BM MNCs (n = 6). Data represent the means ± SEMs.
(B) Relative cell numbers of BM MNCs, Lin cells, and CD34 LSK cells in aged HIF-1aD/D mice (56–74 weeks) compared to aged HIF-1a+/+ littermates (set to
100%) analyzed by flow cytometry (mean ± SEM, n = 6).
(C and D) Oxygenation status of 24-week-old BM Tie2+ LSK cells (C) or CD150+ CD48 CD41 LSK cells (D) subfractionated into highly (30%, navy; Pimo+++),
moderately (40%, blue; Pimo++), or weakly (30%, pale blue; Pimo+) Pimo-positive BM fractions, as in Figure 1A. The total cell number in HIF-1a+/+ BMwas set to
100%.
(E) Flow cytometric analysis of the splenic LSK fraction in aged HIF-1aD/Dmice (56–74 weeks) compared to aged HIF-1a+/+ littermates. LSK fraction is indicated.
Numbers indicate the percentage of total BM MNCs (n = 4). Data represent the means ± SEMs.
(F) Histological examination of spleen from aged HIF-1aD/D mice (56–74 weeks) compared to aged HIF-1a+/+ littermates. Representative pictures of spleen
sections stained by hematoxylin and eosin. Scale bars represent 200 mm.
(G) Survival curves of lethally irradiated recipient mice transplanted with 1 3 106 mononuclear cells from aged HIF-1a+/+ or HIF-1aD/D mouse spleens (n = 10).
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HIF-1a/VHL Regulatory System in HSC Homeostasiskinetics of the HIF-1aD/D HSCs was directly examined by multi-
color flow cytometry. Specific activation of the cell cycle, char-
acterized by a reduction in the Ki67G0 fraction and an increase
in the Ki67+ G1 fraction, was detected in HIF-1aD/D CD34 LSK
cells by flow cytometric analysis (Figure 4B). Because the G0
phase in the CD34+ LSK fraction was identical between the
two genotypes (data not shown), the requirement of HIF-1a for
cell cycle quiescence is mainly restricted to LT-HSCs.
Our HIF-1a loss of function results suggested that HIF-1a is
essential for cell cycle regulation in HSCs. To verify this notion
precisely, we prepared Mx1-Cre:VHL+/flox, Mx1-Cre:VHLflox/flox
mice and Mx1-Cre:HIF-1aflox/flox VHLflox/flox mice. Excision of
one (VHL+/D mice) or two (VHLD/D mice) alleles of the VHL gene
by pIpC-induced Cre expression stabilized the HIF-1a protein
in vivo in a VHL dose-dependent manner. The accumulation
of HIF-1a protein was reversed by codeletion of HIF-1a with
VHL (data not shown). However, pIpC injection into
Mx1-Cre:VHLflox/flox orMx1-Cre:HIF-1aflox/flox VHLflox/floxmice re-
sulted in a 100% mortality rate within 1 week (data not shown).
These deaths were hematopoiesis-independent events, given
that BM replacement by wild-type MNCs in Mx1-Cre:VHLflox/flox396 Cell Stem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier Inor Mx1-Cre:HIF-1aflox/flox VHLflox/flox mice through BMT did not
alter the results after pIpC injection (data not shown).
Therefore, we next analyzed the BM of VHL+/D mice. VHL+/D
CD34- LSK cells showed an increase in G0 and S/G2/M phase
cells, and a decrease in G1 phase cells (Figure 4C). Interestingly,
the VHL+/D CD34+ LSK cells displayed an increased fraction of
G0 phase and a reduced fraction of G1 phase cells (Figure 4D).
These observations suggest that the increased dose of HIF-1a
induced the G0 state in primitive hematopoietic cells, even in
progenitor cells. CD34+ LSK cells in VHL+/D mice exhibited
a higher quiescence induction efficiency (36.3% in VHL+/+ versus
58.6% in VHL+/D) than CD34 LSK cells (79.0% in VHL+/+ versus
88.7% in VHL+/D). This result is potentially due to the increased
destruction of HIF-1a protein in hypoxic CD34+ LSK cells in the
presence of two alleles of the VHL gene, through Phd2-mediated
hydroxylation (Figures 1G–1K).
These cell cycle phenotypes were also confirmed by Pyronin Y
staining or short-term BrdU labeling. In Pyronin Y analysis,
HIF-1aD/D CD34 LSK cells but not CD34+ LSK cells showed
a decreased Pyronin Y- quiescent fraction (Figures S3B–S3D).
In contrast, VHL+/D CD34+ LSK cells but not CD34 LSK cellsc.
Figure 4. HIF-1a Dose-Dependent Regulation of Cell Cycle, Cell Number, and HSC Ability In Vivo
(A) Survival in response to sequential myelosuppressions (5-FU, 150 mg/kg at 10 day intervals) in HIF-1a+/+ or HIF-1aD/D mice (n = 16).
(B–D) Flow cytometric analysis of the cell cycle in the CD34-LSK fraction fromHIF-1a+/+ orHIF-1aD/Dmice (B), and the CD34 LSK (C) or CD34+ LSK (D) fractions
from VHL+/+ or VHL+/D mice (mean ± SD, n = 6; *p < 0.002).
(E) Schematic diagram of the VHLD/D or HIF-1aD/D:VHLD/D BM mouse models.
(F and G) Flow cytometric analysis of the BMHSC fraction in VHLD/D (F) orHIF-1aD/D:VHLD/D (G) BMmice and controls. Numbers indicate themean percentage of
gated cells. Amounts in parentheses indicate the mean percentage of all donor-derived BM MNCs (n = 5, *p < 0.01).
(H) Quantification of the proportion of Ki67-positive cells in LSK cells assessed by immunocytochemistry. A significant reduction in the Ki67-positive cell fraction
was observed in VHLD/D LSK cells, but not in HIF-1aD/D: VHLD/D LSK cells compared to controls. Data represent the means ± SD.
(I) PB chimerism of VHL+/+, VHLD/D, HIF-1a+/+:VHL+/+, and HIF-1aD/D:VHLD/D donor–derived LSK cells (2000 cells) transplanted into lethally irradiated Ly5.1 con-
genic recipients with Ly5.1 competitor cells 4 months after BMT (mean ± SEM, n = 5).
See also Figure S3.
Cell Stem Cell
HIF-1a/VHL Regulatory System in HSC Homeostasisshowed an increased Pyronin Y quiescent fraction (Figures
S3B–S3D). Also, short-term BrdU labeling demonstrated that
cycling cells were high in the HIF-1aD/D CD34 LSK population
but not in the HIF-1aD/D CD34+ LSK cell population (Figures
S3E and S3F). In VHL+/D mice, a decreased cycling status was
only observed in VHL+/DCD34+ LSK cells (Figures S3E and S3F).
To overcome the difficulty in deleting two alleles of the VHL
gene in HSCs, we prepared recipient mice with pIpC-un-
treated Mx1-Cre:VHLflox/flox BM MNCs or Mx1-Cre:HIF-1aflox/flox
VHLflox/flox BM MNCs (Figure 4E). Deletion of the VHL gene by
pIpC injections after BMT induced stabilization of the HIF-1a
protein in the nucleus in 97% of LSK cells, and no death was
observed following pIpC injections (data not shown). Analysis ofCellthe BM showed that there was no significant change in the LSK
fraction and significant accumulation of CD34 LSK cells in the
VHLD/DBMmodel (Figure 4F). This effect wasHIF-1a dependent,
given that codeletion of HIF-1a and VHL in the HIF-1aD/D:VHLD/D
BM model prevented the accumulation of CD34 LSK cells
(Figure 4G). Analysis of the LSK fraction showed that a significant
reduction inKi67+ (i.e., non-G0) cells occurred inVHLD/DLSKcells
(Figure 4H), but not in HIF-1aD/D:VHLD/D LSK cells (Figure 4H).
Therefore, in addition to the accumulation of phenotypical HSCs
in the VHLD/D BM model, induction of cell cycle quiescence was
also HIF-1a dependent.
Because a low expression of CD34 in LSK cells is not only
a feature of functional HSCs but also a hallmark of attenuatedStem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier Inc. 397
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Figure 5. Homing Capacity and Apoptosis in HIF-1aD/D or VHLD/D HSCs
(A and B) Homing capacity of CFSE-labeled 23 105 Lin- Sca-1+ cells fromHIF-1a+/+ orHIF-1aD/Dmice to BM (A) or spleen (B) 16 hr after BMT (n = 5, mean ± SD).
(C and D) Annexin V+ apoptotic cells in CFSE+ transplanted HIF-1a+/+ or HIF-1aD/D Lin Sca-1+ cells 16 hr after BMT (n = 5, mean ± SD).
(E) Annexin V+ apoptotic cells in HIF-1a+/+ or HIF-1aD/D BM CD34 LSK cells (n = 4, mean ± SD).
(F) Redox-sensitive MitoTracker fluorescence in HIF-1a+/+ or HIF-1aD/D BM CD34 LSK cells (n = 3, mean ± SD).
(G and H) Homing capacity of CFSE-labeled 23 105 Lin Sca-1+ cells from control wild-type BM, VHLD/D BM, or HIF-1aD/D:VHLD/D BMmice to BM (G) or spleen
(H) 16 hr after BMT (n = 4–5, mean ± SD).
(I and J) Annexin V+ apoptotic cells in CFSE+ transplanted Lin Sca-1+ cells from control wild-type BM, VHLD/D BM, or HIF-1aD/D:VHLD/D BM mice to BM (I) or
spleen (J) 16 hr after BMT (n = 4–5, mean ± SD).
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HIF-1a/VHL Regulatory System in HSC HomeostasisHSCs (Sudo et al., 2000), we tested the transplantation capacity
of VHLD/D LSK cells. Isolated VHL+/+ LSK, VHLD/D LSK, HIF-
1a+/+:VHL+/+ LSK, or HIF-1aD/D:VHLD/D LSK donor-derived cells
(2000 cells) were transplanted into lethally irradiated Ly5.1
congenic recipients with Ly5.1 competitor cells. The PB recon-
stitution ability of VHLD/D LSK cells was severely impaired in
recipients 4 months after BMT (Figure 4I). This was dependent
on HIF-1a, given that HIF-1aD/D:VHLD/D LSK cells achieved
a PB chimerism comparable to the control (Figure 4I). The HIF-
1aD/D:VHLD/D donor-derived cells also hadmultilineage reconsti-
tution capacities (data not shown). The CD150+ CD48 CD41
LSK fraction decreased in the VHLD/D BM mouse (Figure S3G).
Because there was no significant difference in the frequency of
CD150+ CD48 CD41 LSK in HIF-1aD/D:VHLD/D BM mice
(Figure S3G), the decreased HSC level after biallelic loss of
VHL is considered to be a HIF-1a-dependent event. Therefore,
in addition to the loss of HIF-1a function in HSCs, HIF-1a over-
expression also induces abnormal cell cycle kinetics and
suppresses the stem cell ability in vivo. These data demonstrate
that precise regulation of the HIF-1a dose is critical to maintain-
ing cell cycle kinetics and the HSC capacity during BMT in
primitive hematopoietic cells.Homing Capacity, Apoptosis, and ROS Production
in HIF-1aD/D or VHLD/D HSCs
To characterize the repopulation defect in HIF-1aD/D or
VHLD/D HSCs, we tested the homing capacity and viability of
HIF-1aD/D or VHLD/D progenitors after transplantation. First,398 Cell Stem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier InHIF-1aD/D Lin Sca-1+ primitive BM cells were sorted, CFSE-
labeled, and transplanted into lethally irradiated recipients.
Sixteen hours after BMT, recipient BMand spleenwere analyzed.
Homing capacity and apoptotic cell ratio of transplanted CFSE+
cells in BM or spleen were equivalent in the two genotypes
(Figures 5A–5D). Annexin V+ apoptotic cells in HIF-1aD/D HSC
were also unchanged at the static state (Figure 5E). Therefore,
the repopulation defect of HIF-1aD/D HSCs cannot be attributed
to homing or a cell survival defect. Because an increasedproduc-
tion of ROS, an inducer of cell cycling and senescence in HSCs
(Miyamoto et al., 2007), was observed in HIF-1aD/D CD34 LSK
cells (Figure 5F), the ROS-mediated overproliferation of HIF-
1aD/D HSCs could account for the loss of their stem cell charac-
teristics through senescence-associated events.
In sharp contrast, defective homing to the BM and spleen was
observed in VHLD/D Lin Sca-1+ primitive BM cells (Figures 5G
and 5H). The apoptotic cell ratio in transplanted cells was sup-
pressed by codeletion of HIF-1a in VHLD/D cells homed to the
spleen, but not to the BM (Figures 5I and 5J). These observations
suggest that, in addition to suppression of the cell cycle, VHLD/D
HSCs lose their stem cell capacity in part through defective
homing and increased apoptosis of transplanted cells with an
aberrantly high level of HIF-1aLoss of One VHL Allele Ameliorated Stress Resistance
of HSCs during Aging or BMT
The loss of two alleles of VHL resulted in a transplantation defect





Figure 6. Analysis of VHL+/D HSCs upon Aging or Transplantation
(A andB) Flow cytometric analysis of putative HSC fractions. FACS plots of VHL+/+ orVHL+/DBM in one-year-oldmice. LTHSC (CD150+CD48CD41 LSK) (A) or
LSK Flt3 CD34 (B) fractions are indicated. Numbers indicate the percentage of total BM MNCs (n = 3). Data represent the means ± SDs.
(C) Relative cell numbers of BM MNCs, Lin cells, CD34 Flt3 LSK cells, and CD150+ CD48 CD41 LSK cells in aged VHL+/Dmice (1 years old) compared to
aged VHL+/+ littermates (set to 100%) as analyzed by flow cytometry (mean ± SEM, n = 3).
(D) Redox-sensitive MitoTracker fluorescence in 1-year-old VHL+/+ or VHL+/D BM CD150+ CD48 CD41 LSK cells (n = 3, mean ± SD).
(E) PB chimerism in primary BMT recipients of VHL+/+ (white boxes) or VHL+/D LSK (gray boxes) cells at the indicated times after BMT (mean ± SD, n = 5).
(F) Differentiation status (CD4/CD8+ T cells, B220+ B cells, or Mac-1/Gr-1+myeloid cells) of donor-derived (Ly5.2+) PB cells in primary BMT recipients of VHL+/+ or
VHL+/D LSK cells (mean ± SD, n = 5).
(G) Donor-derived (Ly5.2+) BM MNC, Lin, LSK, or CD34 LSK chimerism in primary BMT recipients of VHL+/+ or VHL+/D LSK cells 4 months after BMT
(mean ± SD, n = 5).
See also Figure S4.
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HIF-1a/VHL Regulatory System in HSC HomeostasisAlthough the PB cell count in VHLD/D BM mouse was equivalent
to that in the control (Figure S4A), the PB differentiation status
was also attenuated in VHLD/D BMmice (Figure S4B). This could
be potentially due to the hyperactivation of HIF-1a in HSCs. To
investigate the optimal HIF-1a dose in vivo, we employed the
loss of one VHL allele for stress resistance of HSCs, which
showed enhanced quiescence in the HSC and progenitor frac-
tion (Figures 4C and 4D) and normal PB differentiation capacity
(Figure S4C). Aged (one-year-old) VHL+/+ or VHL+/D BM showed
a significant increase in CD150+ CD48 CD41 LSK and CD34
Flt3 LSK frequencies upon the deletion of one VHL allele
(Figures 6A and 6B). A significant increase of CD150+ CD48CellCD41 LSK cell number and a tendency for a greater CD34
Flt3 LSK cell number in VHL+/D BM were also observed
(Figure 6C). At this time, ROS generation in the CD150+ CD48
CD41 LSK fraction was suppressed in VHL+/D mice (Fig-
ure 6D). Next, to test the resistance of VHL+/D HSCs to BMT
stress, we transplanted 12-week-old VHL+/D LSK cells, which
had an identical number and frequency of HSCs compared to
wild-type LSK cells (data not shown), into lethally irradiated
recipients with competitor cells. PB chimerism was comparable
between VHL+/+ or VHLD/D cell recipients (Figure 6E). Although
the differentiation status of the donor-derived PB cells was
also identical (Figure 6F), BM chimerism of the LSK or CD34Stem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier Inc. 399
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HIF-1a/VHL Regulatory System in HSC HomeostasisLSK fraction was significantly improved (Figure 6G). Collectively,
the loss of one VHL allele ameliorated HSC maintenance under
stress conditions, such as aging and BMT.
DISCUSSION
Critical regulation of HSC cell cycle quiescence by HIF-1a has
important implications for understanding the regulation of stem
cell homeostasis by the microenvironment. In the present study,
we investigated the role of the relatively hypoxic nature of HSCs
among BM cells, and clarified the significance of that hypoxia in
modulating HSC quiescence through the HIF-1a/VHL regulatory
system. The HIF-1a protein is preferentially expressed in
LT-HSCs, probably because HIF-1a mRNA is preferential
expressed in CD34 LSK cells (Figure 1C). In addition, a specific
HIF-1a degradation mechanism in CD34+ LSK cells could exist
even under hypoxia or cytokine stimulation. A higher level of
expression of Phd2 in CD34+ LSK might account for the mecha-
nism (Figure 1K). Also, the differential responses to cytokines or
hypoxia in LT-HSCs and CD34+ LSK cells suggest that the signal
transduction pathway that transduces cytokines or hypoxia
signals to induce HIF-1a stabilization are different in these cells
(Figure S1C). Consistent with the hypothesis that the entry of
HSCs into the cell cycle influences their life span, we found
that the fraction of quiescent HSCs decreased and that
HIF-1aD/D HSCs were lost during stressed conditions, including
serial transplantation and aging. The Ink4a locus, which
produces p16Ink4a and p19Arf transcripts, is known to contribute
to the aging and exhaustion of HSCs (Naka et al., 2008). LSK
chimerism was decreased in primary recipients in an Ink4a-
dependent manner. Suppression of Ink4a products by Bmi1
induced the recovery of PB and BM repopulation in recipient
mice. During the process of aging, HSCs decreased in number
in the BM, lost their hypoxic nature, and showed extramedullary
hematopoiesis. Conventional HIF-1 targets, including Vegfa,
Epo, and Cxcr4, were not dysregulated in HIF-1aD/D mice
(Figures S2M–S2P). Bmi1 is essential for proper oxygen metab-
olism in mitochondria (Liu et al., 2009). Therefore, it may be that
the observed Bmi1-mediated rescue of the BM repopulation
ability in HIF-1aD/D HSCs was partly regulated by the metabolic
pathway. Overall, HIF-1a plays multiple unique roles for the
proper maintenance of HSCs in vivo.
HSCs, which have few mitochondria, may remain quiescent in
the cell cycle by using anaerobic metabolism in the hypoxic
endosteal zone (Parmar et al., 2007; Kim et al., 1998). HIF-1a is
an essential regulator for cellular metabolic adaptation to
hypoxia (Semenza, 2007). Because HSCs have relatively fewer
mitochondria than proliferating progenitors (Kim et al., 1998),
anaerobic respiration, low oxygen consumption, and low ROS
production regulated by HIF-1a might comprise an effective
survival strategy for BM HSCs under conditions of limited
oxygen supply. In our preliminary data, glycolytic pathways
were predominant in the energy metabolism of wild-type
HSCs, whereas gene expression levels of Glut1 (a transporter
for glucose intake) and pyruvate dehydrogenase kinase (Pdk)
were downregulated in the HSCs of HIF1aD/D mice. These data
suggest that glycolytic pathway regulation by HIF-1a is critical
for the maintenance of quiescent HSCs (K.T. and T.S., unpub-
lished data).400 Cell Stem Cell 7, 391–402, September 3, 2010 ª2010 Elsevier InIn contrast toHIF-1aD/DHSCs, deletion of one or two alleles of
VHL stabilized the HIF-1a protein and induced HSC quiescence
in a HIF-1a dose-dependent manner. Interestingly, in addition to
the HSCs, the progenitor fraction of VHL+/D mice also became
quiescent. In our analysis, the cell cycle status of HIF-1aD/D
progenitors was identical to controls. Therefore, normal progen-
itors do not constitutively stabilize HIF-1a in vivo, but can utilize
HIF-1a protein to become quiescent. Because rapid progenitor
proliferation is required for proper hematopoiesis, specific
HIF-1a destruction mechanisms in progenitors are important,
as is the relatively nonhypoxic nature of progenitors. These
data confirm the significance of the HIF-1a-mediated oxygen
metabolism changes and characterize HSCs and progenitors
in terms of the cell cycle. Overstabilization of the HIF-1a protein
in VHLD/D BM mice also perturbed the ability of HSCs during
BMT; this wasmediated in part by a homing defect and an atten-
uated viability during BMT (Figure 5). This is consistent with the
previous finding that the forced expression of GATA2, an essen-
tial regulator of HSC quiescence, results in loss of stem cell
capacity in human HSCs (Tipping et al., 2009). Recently, it was
reported that Cited2, a negative regulator for HIF-1a, selectively
maintains adult HSC functions, at least in part, via Ink4a/Arf and
Trp53 (Kranc et al., 2009). Collectively, these data indicate that
precise regulation of the appropriate HIF-1a dose in HSCs is
essential for determining the cell cycle status and stem cell
capacity of HSCs. In support of this, loss of one VHL allele pref-
erentially affected HSCs during aging and BMT (Figure 6).
Hypoxic quiescent HSCs are dispersed, and do not accumu-
late, in the theoretically hypoxic BM endosteal zone (Figures
1D–1F). This BM zone is highly vascularized, and transplanted
HSCs attach to endothelial cells and leave the vasculature to
migrate deep into the BM (sometimes near the osteoblastic cells)
(Lo Celso et al., 2009; Xie et al., 2009). The putative HSCswith an
intracellular hypoxic status included the less-differentiated
Tie2+ LSK or CD150+ CD48 CD41 LSK cells (Figures 1B, 3C,
and 3D). Because CD150+ CD48 CD41 LSK cells were origi-
nally identified as vasculature-associated cells (Kiel et al.,
2005), the HSC oxygenation status has been proposed to be
independently regulated by the association of these cells with
the vasculature. In support of this hypothesis, loss of HIF-1a
affected the intracellular oxygenation status of HSCs (Figures
3C and 3D).
The critical role for HIF-1a in HSC cell cycle regulation
broadens the concept of stem cell niche involvement in the
oxygenation status. It also implies a strategy for maintaining
and expanding HSC resources based on cellular oxygen metab-
olism reprogramming, including the modulation of HSC quies-
cence through the cell oxygenation status of HIF-1a.EXPERIMENTAL PROCEDURES
Mice
HIF-1aflox/flox (Ryan et al., 1998) or VHLflox/flox mice (Haase et al., 2001) were
crossed to the C57BL/6 background for more than ten generations and
were mated to interferon-inducible Mx1-cre transgenic mice (Kuhn et al.,
1995) for generation of Mx1-cre:HIF-1a flox/flox or Mx1-cre:VHLflox/flox mice.
Offspring of these mice were genotyped by PCR-based assays with DNA
from mouse tail snips. To prepare HIF-1aD/D mice, Mx1-cre expression was
induced by intraperitoneal injection of 400 mg of pIpC (Amersham), on three
alternate days, into 4- to 8-week-old mice. At least 4 weeks after pIpCc.
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HIF-1a/VHL Regulatory System in HSC Homeostasisinjection, 10 to 12-week-old mice were used in each experiment, unless stated
otherwise. We utilized age-matched pIpC-injected Mx1-cre:HIF-1a+/+ or Cre
(-):HIF-1a flox/flox mice as controls (HIF-1a+/+ mice). C57BL/6-Ly5.1 congenic
or C57BL/6-Ly5.1/Ly5.2 F1 mice were used for competitive repopulation
assays.
To prepare mice with VHLD/D or HIF-1aD/D:VHLD/D BM (VHLD/D or HIF-
1aD/D:VHLD/D BM mice), we transplanted (0.6-1) 3 107 BM MNCs or CD45+
BM MNCs from Mx1-cre:VHLflox/flox or Mx1-cre:HIF-1a flox/flox: VHLflox/flox
mice into lethally irradiated C57BL/6-Ly5.1 mice. We checked for PB chime-
rism 6 weeks after BMT and utilized recipients with >90% donor-derived cells.
Cre expression in the replaced BM was induced by intraperitoneal injection of
250 mg of pIpC (Amersham) on three alternate days. We used Mx1-cre:HIF-
1a+/+:VHL+/+BMmice as controls (VHL+/+ BMmice). For blood count analysis,
PB from the postorbital vein was collected in heparinized microtubes (Drum-
mond Scientific) and analyzed using CellTac (Nihon Kohden). All procedures
were performed in accordance with the guidelines of Keio University School
of Medicine.
Flow Cytometry
Analysis of various HSC fractions were essentially performed as previously
described (Arai et al., 2004).
Immunocytochemistry and Immunohistochemistry
Immunocytochemistry with isolated cells was performed as described previ-
ously (Takubo et al., 2008). For preparation of cultured cells, sorted cells
were incubated under normoxia (20% O2) or hypoxia (1% O2) for 12 hr in
serum-free SF-O3 medium (Sanko Jyunyaku). For histological BM examina-
tion, fresh frozen BM sections (6 mm thickness) of the femoral bone were
prepared with a cryostat equipped with a tungsten blade (Microedge Instru-
ments). Sections were placed onto MAS-coated glass slides (Matsunami
Glass), dried completely, and fixed with 4% PFA for 10 min, and subsequently
stained with antibody. Care was taken to avoid any detachment of the bony
portion.
Bone Marrow Transplants, Progenitor Assays, and Peripheral
Blood Analysis
LSK cells from HIF-1a+/+ or HIF-1aD/D mice (Ly5.2), together with 4 3 105 BM
MNCs from C57Bl/6-Ly5.1 mice, were transplanted into lethally irradiated
C57Bl/6-Ly5.1 congenic mice. Secondary transplantations into lethally irradi-
ated C57Bl/6-Ly5.1 congenic mice were performed with Ly5.2+ LSK cells from
primary recipients, together with 43 105 BMMNCs from C57Bl/6-Ly5.1 mice.
Recipient mice were sacrificed for analysis 4 months after BMT. For splenic
cell transplantation, 1 3 106 splenic MNCs from HIF-1a+/+ or HIF-1aD/D mice
(Ly5.2) were transplanted into lethally irradiated C57Bl/6-Ly5.1 congenic
mice. Examination of the progenitor capacity by CFU-C, CFU-S12, and BMT
with CD34+ LSK cells was performed as previously described (Miyamoto
et al., 2007).
Statistical Analysis
Data are presented as the means ± SD, unless stated otherwise. Statistical
significance was determined by Tukey’s multiple comparison test. For
comparison of a two-group experiment, the two-tailed Student’s t test was
usedwith the exception of the 5-FU survival assay and BMT assay with splenic
MNCs, which were analyzed with the log-rank test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/
j.stem.2010.06.020.
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